By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Novartis AG 

Lichtstrasse 35

Basel    CH-4056  Switzerland
Phone: 41-0-61-3241111 Fax: 41-0-61-3248001


Novartis is located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG, which provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care and cost-saving generic pharmaceuticals. Novartis is the only global company with leading positions in these areas. In 2015, the Group achieved net sales of USD 49.4 billion, while R&D throughout the Group amounted to approximately USD 8.9 billion (USD 8.7 billion excluding impairment and amortization charges). Novartis Group companies employ approximately 118,000 full-time-equivalent associates. Novartis products are available in more than 180 countries around the world.

For more information, visit and follow us on




CEO: Joseph Jimenez

CMO: Vasant (Vas) Narasimhan

CFO: Harry Kirsch


Please click here for Novartis job opportunities.


Please click here for clinical trial information.


All Products


Key Statistics

Ownership: Subsidiary

Web Site: Novartis AG
Symbol: NVS


Company News
Novartis AG (NVS) And The Max Foundation Transform Pioneering Cancer Access Program For People In Lower-Income Countries 9/22/2017 8:09:21 AM
Novartis AG (NVS)' 475,000 CAR-T Drug Price Comes Under Fire 9/22/2017 6:38:12 AM
Novartis AG (NVS) Drug Rydapt (Midostaurin) Receives EU Approval For Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML) And Three Types Of Advanced Systemic Mastocytosis (SM) 9/20/2017 10:11:32 AM
Novartis AG (NVS) Release: New Analysis Shows Entresto Improved Physical And Social Activity In Patients With HFrEF 9/19/2017 7:45:38 AM
Aerie (AERI) Poaches Another Exec From Novartis AG (NVS)' Tormented Alcon (ACL) Biz 9/19/2017 6:40:08 AM
Novartis AG (NVS)' Xolair Confirms Re-Treatment Efficacy In Chronic Spontaneous Urticaria Patients After Treatment Interruption 9/18/2017 10:34:54 AM
Novartis AG (NVS) Returns Global Eye Drug Rights To ThromboGenics NV (TBGNF) 9/18/2017 6:19:03 AM
Novartis AG (NVS) Unloads Former New York Space for $18 Million, Resold for $30 Million 9/15/2017 6:36:23 AM
Novartis AG (NVS) Teams Up With Actress, Producer And Activist Eva Longoria To Launch Kiss This 4 MBC To Generate Research Funding And Support For The Metastatic Breast Cancer Community 9/14/2017 11:14:03 AM
Novartis AG (NVS) Posts Stunning 5-Year Sustained Late-Stage Psoriasis Data 9/13/2017 5:42:46 AM